Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis

Tsutomu Takeuchi, Nobuyuki Miyasaka, Yoshihiko Tatsuki, Toshiro Yano, Toru Yoshinari, Tohru Abe, Takao Koike

Research output: Contribution to journalArticlepeer-review

108 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds